aluates Reports

$ 0.0

Automative

Global Sexually Transmitted Diseases (STD) Diagnostics Market Research Report 2026

Published Date: 2026-03-31

Report Code: QYRE-Auto-5X17466

Global Sexually Transmitted Diseases STD Diagnostics Market Research Report 2024

BUY CHAPTERS

Global Sexually Transmitted Diseases (STD) Diagnostics Market Research Report 2026

Code: QYRE-Auto-5X17466

Report

2026-03-31

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Thermo Fisher Scientific Inc

Hologic Inc

Creative Diagnostics

Abbott Laboratories

Quest Diagnostics

Qiagen NV

Cepheid Inc

Biomerieux

Sexually Transmitted Diseases (STD) Diagnostics Market

The global Sexually Transmitted Diseases (STD) Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Sexually Transmitted Diseases (STD) Diagnostics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Sexually Transmitted Diseases (STD) Diagnostics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Sexually Transmitted Diseases (STD) Diagnostics in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Sexually Transmitted Diseases (STD) Diagnostics include F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Sexually Transmitted Diseases (STD) Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Diagnostics. The Sexually Transmitted Diseases (STD) Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sexually Transmitted Diseases (STD) Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sexually Transmitted Diseases (STD) Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sexually Transmitted Diseases (STD) Diagnostics Market Report

Report Metric	Details
Report Name	Sexually Transmitted Diseases (STD) Diagnostics Market
Segment by Type	Molecular Test Serologic Test Point of Care Test Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sexually Transmitted Diseases (STD) Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Sexually Transmitted Diseases (STD) Diagnostics Market report?

Ans: The main players in the Sexually Transmitted Diseases (STD) Diagnostics Market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc.

What are the Application segmentation covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report?

Ans: The Applications covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report?

Ans: The Types covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report are Molecular Test, Serologic Test, Point of Care Test, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Molecular Test

1.2.3 Serologic Test

1.2.4 Point of Care Test

1.2.5 Others

1.3 Market by Application

1.3.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Perspective (2021–2032)

2.2 Global Sexually Transmitted Diseases (STD) Diagnostics Growth Trends by Region

2.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 Sexually Transmitted Diseases (STD) Diagnostics Market Dynamics

2.3.1 Sexually Transmitted Diseases (STD) Diagnostics Industry Trends

2.3.2 Sexually Transmitted Diseases (STD) Diagnostics Market Drivers

2.3.3 Sexually Transmitted Diseases (STD) Diagnostics Market Challenges

2.3.4 Sexually Transmitted Diseases (STD) Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Revenue

3.1.1 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Revenue (2021–2026)

3.1.2 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sexually Transmitted Diseases (STD) Diagnostics Revenue

3.4 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio

3.4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2025

3.5 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics Head Offices and Areas Served

3.6 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Products and Applications

3.7 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Type

4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (2027–2032)

5 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Application

5.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)

6.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)

6.4 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)

7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)

7.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)

9.2 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)

9.4 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F.Hoffmann-La Roche Ltd

11.1.1 F.Hoffmann-La Roche Ltd Company Details

11.1.2 F.Hoffmann-La Roche Ltd Business Overview

11.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.1.4 F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.1.5 F.Hoffmann-La Roche Ltd Recent Development

11.2 Thermo Fisher Scientific Inc.

11.2.1 Thermo Fisher Scientific Inc. Company Details

11.2.2 Thermo Fisher Scientific Inc. Business Overview

11.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.2.4 Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.2.5 Thermo Fisher Scientific Inc. Recent Development

11.3 Hologic Inc.

11.3.1 Hologic Inc. Company Details

11.3.2 Hologic Inc. Business Overview

11.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.3.4 Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.3.5 Hologic Inc. Recent Development

11.4 Creative Diagnostics

11.4.1 Creative Diagnostics Company Details

11.4.2 Creative Diagnostics Business Overview

11.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.4.4 Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.4.5 Creative Diagnostics Recent Development

11.5 Abbott Laboratories

11.5.1 Abbott Laboratories Company Details

11.5.2 Abbott Laboratories Business Overview

11.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.5.4 Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.5.5 Abbott Laboratories Recent Development

11.6 Quest Diagnostics

11.6.1 Quest Diagnostics Company Details

11.6.2 Quest Diagnostics Business Overview

11.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.6.4 Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.6.5 Quest Diagnostics Recent Development

11.7 BD

11.7.1 BD Company Details

11.7.2 BD Business Overview

11.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.7.4 BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.7.5 BD Recent Development

11.8 QIAGEN

11.8.1 QIAGEN Company Details

11.8.2 QIAGEN Business Overview

11.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.8.4 QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.8.5 QIAGEN Recent Development

11.9 Cepheid

11.9.1 Cepheid Company Details

11.9.2 Cepheid Business Overview

11.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.9.4 Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.9.5 Cepheid Recent Development

11.10 bioMerieux Inc.

11.10.1 bioMerieux Inc. Company Details

11.10.2 bioMerieux Inc. Business Overview

11.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction

11.10.4 bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

11.10.5 bioMerieux Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Thermo Fisher Scientific Inc

Hologic Inc

Creative Diagnostics

Abbott Laboratories

Quest Diagnostics

Qiagen NV

Cepheid Inc

Biomerieux

List of Tables

Table 1. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Molecular Test

Table 3. Key Players of Serologic Test

Table 4. Key Players of Point of Care Test

Table 5. Key Players of Others

Table 6. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2021–2026)

Table 10. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2027–2032)

Table 12. Sexually Transmitted Diseases (STD) Diagnostics Market Trends

Table 13. Sexually Transmitted Diseases (STD) Diagnostics Market Drivers

Table 14. Sexually Transmitted Diseases (STD) Diagnostics Market Challenges

Table 15. Sexually Transmitted Diseases (STD) Diagnostics Market Restraints

Table 16. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 17. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Players (2021–2026)

Table 18. Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sexually Transmitted Diseases (STD) Diagnostics Revenue, 2025

Table 19. Ranking of Global Top Sexually Transmitted Diseases (STD) Diagnostics Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Products and Applications

Table 23. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 26. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Type (2021–2026)

Table 27. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Type (2027–2032)

Table 29. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 30. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Application (2021–2026)

Table 31. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Application (2027–2032)

Table 33. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 35. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 48. F.Hoffmann-La Roche Ltd Company Details

Table 49. F.Hoffmann-La Roche Ltd Business Overview

Table 50. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product

Table 51. F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 52. F.Hoffmann-La Roche Ltd Recent Development

Table 53. Thermo Fisher Scientific Inc. Company Details

Table 54. Thermo Fisher Scientific Inc. Business Overview

Table 55. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product

Table 56. Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 57. Thermo Fisher Scientific Inc. Recent Development

Table 58. Hologic Inc. Company Details

Table 59. Hologic Inc. Business Overview

Table 60. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product

Table 61. Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 62. Hologic Inc. Recent Development

Table 63. Creative Diagnostics Company Details

Table 64. Creative Diagnostics Business Overview

Table 65. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product

Table 66. Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 67. Creative Diagnostics Recent Development

Table 68. Abbott Laboratories Company Details

Table 69. Abbott Laboratories Business Overview

Table 70. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product

Table 71. Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 72. Abbott Laboratories Recent Development

Table 73. Quest Diagnostics Company Details

Table 74. Quest Diagnostics Business Overview

Table 75. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product

Table 76. Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 77. Quest Diagnostics Recent Development

Table 78. BD Company Details

Table 79. BD Business Overview

Table 80. BD Sexually Transmitted Diseases (STD) Diagnostics Product

Table 81. BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 82. BD Recent Development

Table 83. QIAGEN Company Details

Table 84. QIAGEN Business Overview

Table 85. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product

Table 86. QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 87. QIAGEN Recent Development

Table 88. Cepheid Company Details

Table 89. Cepheid Business Overview

Table 90. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product

Table 91. Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 92. Cepheid Recent Development

Table 93. bioMerieux Inc. Company Details

Table 94. bioMerieux Inc. Business Overview

Table 95. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product

Table 96. bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (US$ Million), 2021–2026

Table 97. bioMerieux Inc. Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Sexually Transmitted Diseases (STD) Diagnostics Picture

Figure 2. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. Molecular Test Features

Figure 5. Serologic Test Features

Figure 6. Point of Care Test Features

Figure 7. Others Features

Figure 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application: 2025 vs 2032

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Others Case Studies

Figure 13. Sexually Transmitted Diseases (STD) Diagnostics Report Years Considered

Figure 14. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region: 2025 vs 2032

Figure 17. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Players in 2025

Figure 18. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2025

Figure 20. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)

Figure 22. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)

Figure 26. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2021–2032)

Figure 34. China Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)

Figure 42. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2021–2032)

Figure 46. Israel Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. F.Hoffmann-La Roche Ltd Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 51. Hologic Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 52. Creative Diagnostics Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 53. Abbott Laboratories Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 54. Quest Diagnostics Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 55. BD Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 56. QIAGEN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 57. Cepheid Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 58. bioMerieux Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2021–2026)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sexually Transmitted Diseases STDs Testing Devices Market Research Report 2025

Global STD Tests Market Research Report 2024

Global Sexually Transmitted Diseases Test Kit Market Research Report 2025

Global Chlamydia Infection Diagnostics Market Research Report 2024

Global Diagnostic Testing For STDs Market Insights Forecast to 2030

Global Home Sexually Transmitted Diseases Test Kit Market Research Report 2025

Global Sexually Transmitted Diseases STD Testing Market Insights Forecast to 2030

Chlamydia Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Syphilis Diagnosis Market Research Report 2024

Global STD Testing Kits Market Research Report 2024

Global Sexually Transmitted Disease STD Testing Market Insights Forecast to 2030

Global Sexually Transmitted Diseases Drug Market Research Report 2025

STD Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Diseases Molecular Diagnostics Market Research Report 2025

STD Home Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Disease Testing And Diagnostic Market Research Report 2024

Global Chlamydia Trachomatis Detection Kit Market Research Report 2024

STDs Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chlamydia Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions